Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
154.2 USD | -1.63% |
|
-2.44% | +59.91% |
Jun. 26 | Monetary policy is getting even more confusing | ![]() |
Jun. 26 | Citigroup Downgrades Sarepta Therapeutics to Neutral From Buy, Raises Price Target to $176 From $172 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+59.91% | 14.58B | |
+16.44% | 122B | |
+18.94% | 113B | |
+18.49% | 26.22B | |
-25.37% | 19.01B | |
-19.77% | 15.71B | |
-20.20% | 15.22B | |
-47.37% | 14.72B | |
+4.35% | 13.84B | |
+108.13% | 10.4B |
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- Barclays Adjusts Price Target on Sarepta Therapeutics to $226 From $185, Maintains Overweight Rating